News

Filter

Current filters:

Nesiritide

1 to 9 of 77 results

ARCA renames to reflect new focus

07-04-2008

Denver, USA-based ARCA Discovery, a privately-held company, has changed its name to ARCA biopharma, effective…

Antihemophilic FactorCoagulation Factor VIIaJohnson & JohnsonNatrecorNesiritideRecombinant

J&J subsids receive three US subpoenas

19-03-2007

Global health care giant Johnson & Johnson says that it has received three separate subpoenas from the…

infliximabJohnson & JohnsonNatrecorNesiritideRemicadeRisperdalRisperdal ConstaRisperidoneTopamaxtopiramate

J&J's Scios reports new Natrecor deaths

09-01-2006

Johnson & Johnson subsidiary Scios has submitted an interim report to the US Food & Drug Administration,…

Johnson & JohnsonNatrecorNesiritide

Cilag gains European nesiritide rights

08-08-2005

Cilag GmbH International, a Johnson & Johnson company, is to acquire European marketing and development…

Antihemophilic FactorCoagulation Factor VIIaGlaxoSmithKlineGSKJanssen-CilagJohnson & JohnsonNatrecorNesiritideRecombinant

Scios subpoenaed over Natrecor

01-08-2005

Johnson & Johnson subsidiary Scios says it has received a subpoena from the US Attorney's Office in Boston,…

Johnson & JohnsonNatrecorNesiritide

1 to 9 of 77 results

COMPANY SPOTLIGHT

Menarini

Back to top